[Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques].

D. Bonnefont-Rousselot
DOI: https://doi.org/10.1016/j.pharma.2015.09.002
2016-05-01
Annales Pharmaceutiques Françaises
Abstract:
What problem does this paper attempt to address?